That’s one way that Chiesi Group – an Italian family business-turned-global pharma company – seeks to define itself. A Benefit Corporation since 2018 and a Certified B-Corp since 2019 ...
Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. in an all-cash transaction at $14.50 per American Depositary Share (ADS). Each ADS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback